Healthcare Triangle is trading at $4.36, down 5.63% in pre-market, with no confirmed catalyst for the decline.
- No verified company announcement for November 5 was found. Its Nasdaq delisting appeal hearing is scheduled for that date; continued listing is not assured, though no report links the hearing to the move.
- Shares closed November 4 at $4.62, down 11.83%, extending the weakness. The cited software-sector rally moved in the opposite direction and does not explain the drop.